Voluntary modulation of saccadic peak velocity associated with individual differences in motivation.

Incentives Main sequence Motivation Saccades Voluntary control

Journal

Cortex; a journal devoted to the study of the nervous system and behavior
ISSN: 1973-8102
Titre abrégé: Cortex
Pays: Italy
ID NLM: 0100725

Informations de publication

Date de publication:
01 2020
Historique:
received: 23 04 2018
revised: 21 09 2018
accepted: 04 12 2018
pubmed: 15 1 2019
medline: 22 6 2021
entrez: 15 1 2019
Statut: ppublish

Résumé

Saccadic peak velocity increases in a stereotyped manner with the amplitude of eye movements. This relationship, known as the main sequence, has classically been considered to be fixed, although several recent studies have demonstrated that velocity can be modulated to some extent by external incentives. However, the ability to voluntarily control saccadic velocity and its association with motivation has yet to be investigated. Here, in three separate experimental paradigms, we measured the effects of incentivisation on saccadic velocity, reaction time and preparatory pupillary changes in 53 young healthy participants. In addition, the ability to voluntarily modulate saccadic velocity with and without incentivisation was assessed. Participants varied in their ability to increase and decrease the velocity of their saccades when instructed to do so. This effect correlated with motivation level across participants, and was further modulated by addition of monetary reward and avoidance of loss. The findings show that a degree of voluntary control of saccadic velocity is possible in some individuals, and that the ability to modulate peak velocity is associated with intrinsic levels of motivation.

Identifiants

pubmed: 30638586
pii: S0010-9452(18)30408-8
doi: 10.1016/j.cortex.2018.12.001
pmc: PMC6970223
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

198-212

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00005/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P00878X/1
Pays : United Kingdom

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Exp Brain Res. 2002 Jan;142(2):284-91
pubmed: 11807582
Neuroreport. 1997 Jul 7;8(9-10):2139-42
pubmed: 9243599
Aviat Space Environ Med. 1979 Apr;50(4):393-5
pubmed: 464963
J Neurosci. 2015 Nov 18;35(46):15369-78
pubmed: 26586823
Appl Ergon. 2011 Nov;42(6):807-13
pubmed: 21316645
Neuron. 2006 Sep 21;51(6):861-70
pubmed: 16982429
J Psychopharmacol. 2010 Nov;24(11):1631-40
pubmed: 20142307
Nat Rev Neurosci. 2002 Dec;3(12):952-64
pubmed: 12461552
Sci Rep. 2017 Feb 13;7:42287
pubmed: 28205567
Neuron. 2012 Nov 21;76(4):826-37
pubmed: 23177966
J Neurosci. 1995 Jan;15(1 Pt 2):928-41
pubmed: 7823190
Eur J Neurosci. 2015 Apr;41(8):1102-10
pubmed: 25817064
Neuropsychopharmacology. 2010 Jan;35(1):4-26
pubmed: 19812543
Addict Biol. 2003 Mar;8(1):59-66
pubmed: 12745417
Nat Rev Neurosci. 2004 Mar;5(3):218-28
pubmed: 14976521
Eur J Neurosci. 2013 Aug;38(3):2434-44
pubmed: 23668781
Cortex. 2016 Mar;76:104-20
pubmed: 26874940
J Neurophysiol. 2002 May;87(5):2279-86
pubmed: 11976367
PLoS One. 2017 Jan 11;12(1):e0169938
pubmed: 28076387
Brain. 2016 Oct;139(Pt 10):2706-2721
pubmed: 27452600
Ergonomics. 1998 May;41(5):689-97
pubmed: 9613229
Invest Ophthalmol Vis Sci. 1981 Jul;21(1 Pt 1):116-25
pubmed: 7251295
J Neurosci. 2015 May 20;35(20):7866-77
pubmed: 25995472
Nature. 1998 Aug 20;394(6695):780-4
pubmed: 9723616
Ann N Y Acad Sci. 2007 May;1104:229-49
pubmed: 17360800
J Neurophysiol. 2006 Feb;95(2):567-84
pubmed: 16424448
J Neurol Neurosurg Psychiatry. 2006 May;77(5):579-84
pubmed: 16614016
J Physiol Paris. 2015 Feb-Jun;109(1-3):16-26
pubmed: 24747776
Exp Brain Res. 2009 Jul;196(4):475-81
pubmed: 19526358
Brain. 2004 Mar;127(Pt 3):460-77
pubmed: 14607787
NPJ Parkinsons Dis. 2015 Dec 17;1:15026
pubmed: 28357409
J Neurosci Methods. 2007 May 15;162(1-2):8-13
pubmed: 17254636
J Neurophysiol. 2018 Aug 1;120(2):741-757
pubmed: 29766769
Behav Res Methods. 2014 Dec;46(4):913-21
pubmed: 24258321
Sleep. 2005 Sep;28(9):1109-15
pubmed: 16268380
Neuropsychologia. 2019 Feb 4;123:19-29
pubmed: 30005926
Physiol Rev. 2000 Jul;80(3):953-78
pubmed: 10893428
J Neurosci. 2007 May 2;27(18):4810-8
pubmed: 17475788
Aviat Space Environ Med. 2010 Apr;81(4):413-7
pubmed: 20377146
Annu Rev Neurosci. 2010;33:89-108
pubmed: 20367317
Brain. 2018 Nov 1;141(11):3193-3210
pubmed: 30346491
Front Integr Neurosci. 2014 Jun 20;8:48
pubmed: 24994970
Curr Biol. 2015 Jun 29;25(13):1707-16
pubmed: 26096975
J Neurosci. 2012 Aug 22;32(34):11727-36
pubmed: 22915115
Clin Neurophysiol. 2006 Oct;117(10):2144-53
pubmed: 16920018
Contemp Educ Psychol. 2000 Jan;25(1):54-67
pubmed: 10620381
Curr Opin Neurobiol. 2015 Aug;33:134-40
pubmed: 25863645
J Neurosci. 2014 Jan 22;34(4):1212-23
pubmed: 24453313
Eye (Lond). 2015 Feb;29(2):241-5
pubmed: 25475239
Biol Cybern. 2006 Jul;95(1):21-9
pubmed: 16555070
Psychol Sci. 2017 Jul;28(7):1016-1026
pubmed: 28488927

Auteurs

Kinan Muhammed (K)

Nuffield Department of Clinical Neurosciences, University of Oxford, UK; Department of Experimental Psychology, University of Oxford, UK. Electronic address: kinan.muhammed@ndcn.ox.ac.uk.

Edwin Dalmaijer (E)

Department of Experimental Psychology, University of Oxford, UK.

Sanjay Manohar (S)

Nuffield Department of Clinical Neurosciences, University of Oxford, UK; Department of Experimental Psychology, University of Oxford, UK.

Masud Husain (M)

Nuffield Department of Clinical Neurosciences, University of Oxford, UK; Department of Experimental Psychology, University of Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH